| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Phreesia, Inc. (PHR) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. PHR is classified in the Health Care Technology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.39M | $15.87M | - | |
| Pres | 842.5K | $9.62M | - | |
| Pres | 224.1K | $2.56M | - | |
| VP | 168.9K | $1.93M | - | |
| Other | 163.5K | $1.87M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | Egbuonu-Davis Lisa54 | Director | Sell | 465 | $27.64 | $12,852.60 | -2.1% | -16.8% | -59.7% | |
| Jul 7, 2025 | Hui Yvonne76 | Principal Accounting Officer | Sell | 571 | $28.85 | $16,473.35 | -1.8% | -17.3% | -61.4% | |
| Jul 2, 2025 | Smith Mark Douglas69 | Director | Sale+OE | 7,000 | $29.00 | $203,000.00 | -15.8% | -19.1% | -62.4% | |
| Jun 27, 2025 | Linetsky David71 | SVP, Network Solutions | Sell | 23,729 | $28.50 | $676,195.82 | -10.9% | -17.7% | -64.7% | |
| Jun 26, 2025 | Egbuonu-Davis Lisa54 | Director | Sell | 2,802 | $27.67 | $77,531.34 | -11.3% | -15.3% | -64.0% | |
| Jun 18, 2025 | Linetsky David71 | SVP, Network Solutions | Sell | 109 | $25.44 | $2,773.19 | -0.6% | -8.4% | -63.4% | |
| Jun 10, 2025 | Hui Yvonne76 | Principal Accounting Officer | Sell | 582 | $28.00 | $16,296.00 | -1.8% | -4.4% | -67.4% | |
| Jun 10, 2025 | Weintraub Michael80 | Director | Sale+OE | 10,000 | $27.60 | $276,011.62 | -3.4% | -4.4% | -67.4% | |
| Apr 22, 2025 | Hui Yvonne76 | Principal Accounting Officer | Sell | 2,323 | $23.42 | $54,401.51 | -4.8% | +14.1% | - | |
| Apr 21, 2025 | Linetsky David71 | SVP, Life Sciences | Sell | 260 | $23.04 | $5,990.87 | -2.9% | +14.2% | - |